1. Home
  2. ITGR vs DBD Comparison

ITGR vs DBD Comparison

Compare ITGR & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITGR
  • DBD
  • Stock Information
  • Founded
  • ITGR 1970
  • DBD 1859
  • Country
  • ITGR United States
  • DBD United States
  • Employees
  • ITGR N/A
  • DBD N/A
  • Industry
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DBD EDP Services
  • Sector
  • ITGR Health Care
  • DBD Technology
  • Exchange
  • ITGR Nasdaq
  • DBD Nasdaq
  • Market Cap
  • ITGR 2.4B
  • DBD 2.1B
  • IPO Year
  • ITGR 2000
  • DBD N/A
  • Fundamental
  • Price
  • ITGR $72.09
  • DBD $64.42
  • Analyst Decision
  • ITGR Buy
  • DBD Strong Buy
  • Analyst Count
  • ITGR 8
  • DBD 3
  • Target Price
  • ITGR $92.86
  • DBD $76.67
  • AVG Volume (30 Days)
  • ITGR 994.6K
  • DBD 227.1K
  • Earning Date
  • ITGR 10-23-2025
  • DBD 11-05-2025
  • Dividend Yield
  • ITGR N/A
  • DBD N/A
  • EPS Growth
  • ITGR N/A
  • DBD 43573.14
  • EPS
  • ITGR 2.42
  • DBD 1.35
  • Revenue
  • ITGR $1,831,074,000.00
  • DBD $3,690,400,000.00
  • Revenue This Year
  • ITGR $9.69
  • DBD $3.09
  • Revenue Next Year
  • ITGR $0.48
  • DBD $2.56
  • P/E Ratio
  • ITGR $29.61
  • DBD $47.91
  • Revenue Growth
  • ITGR 9.54
  • DBD N/A
  • 52 Week Low
  • ITGR $62.00
  • DBD $34.88
  • 52 Week High
  • ITGR $146.36
  • DBD $66.28
  • Technical
  • Relative Strength Index (RSI)
  • ITGR 43.28
  • DBD 59.07
  • Support Level
  • ITGR $70.88
  • DBD $59.76
  • Resistance Level
  • ITGR $72.62
  • DBD $65.37
  • Average True Range (ATR)
  • ITGR 1.72
  • DBD 1.95
  • MACD
  • ITGR 1.74
  • DBD -0.01
  • Stochastic Oscillator
  • ITGR 88.42
  • DBD 74.68

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

About DBD Diebold Nixdorf Incorporated Common stock

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

Share on Social Networks: